Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001824893-25-000001
Filing Date
2025-04-08
Accepted
2025-04-08 13:22:34
Documents
1
Effectiveness Date
2025-04-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14023
  Complete submission text file 0001824893-25-000001.txt   15346
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-543181 | Film No.: 25821145
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)